We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$218B
AUM Growth
-$5.41B
Cap. Flow
-$25.1B
Cap. Flow %
-11.51%
Top 10 Hldgs %
47.1%
Holding
5,603
New
345
Increased
2,379
Reduced
1,667
Closed
541

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.82B
2
AAPL icon
Apple
AAPL
+$1.62B
3
UNH icon
UnitedHealth
UNH
+$1.03B
4
XOM icon
ExxonMobil
XOM
+$869M
5
TSLA icon
Tesla
TSLA
+$701M

Sector Composition

Rank Sector Weight
1 Technology 12.19%
2 Consumer Discretionary 5.03%
3 Healthcare 4.78%
4 Financials 4.74%
5 Communication Services 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FXLV
4451
DELISTED
F45 Training Holdings Inc.
FXLV
$24.6K ﹤0.01%
21,179
+10,896
+106% +$25.9K
LEE icon
4452
Lee Enterprises
LEE
$172M
$24.2K ﹤0.01%
1,944
+2
+0.1% +$35
CRESY
4453
Cresud
CRESY
$795M
$23.9K ﹤0.01%
3,900
GTHX
4454
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$23.5K ﹤0.01%
8,765
-17,710
-67% -$85.1K
YELL
4455
DELISTED
Yellow Corporation Common Stock
YELL
$23.4K ﹤0.01%
11,512
-12,674
-52% -$33.8K
GDS icon
4456
GDS Holdings
GDS
$6.56B
$23.2K ﹤0.01%
1,245
-99,333
-99% -$2.1M
PRDS
4457
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$23.2K ﹤0.01%
17,578
+8,359
+91% +$13.7K
HELP
4458
Cybin Inc
HELP
$485M
$23.2K ﹤0.01%
+1,584
New +$25.7K
VIA
4459
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$22.8K ﹤0.01%
1,243
+583
+88% +$16.4K
ATLX icon
4460
Atlas Lithium Corp
ATLX
$80.8M
$22.5K ﹤0.01%
+1,300
New +$15.4K
AREC icon
4461
American Resources Corp
AREC
$191M
$22.5K ﹤0.01%
15,000
CRBN icon
4462
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.15B
$22.5K ﹤0.01%
152
SCHA icon
4463
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$22.5K ﹤0.01%
1,072
TEO icon
4464
Telecom Argentina
TEO
$6.03B
$22.5K ﹤0.01%
4,500
FDBC icon
4465
Fidelity D&D Bancorp
FDBC
$306M
$22.4K ﹤0.01%
491
INMD icon
4466
InMode
INMD
$870M
$22.4K ﹤0.01%
700
-18,165
-96% -$622K
DWAS icon
4467
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$429M
$22.1K ﹤0.01%
300
VALU icon
4468
Value Line
VALU
$321M
$22.1K ﹤0.01%
457
+208
+84% +$10.5K
SPXL icon
4469
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.72B
$22K ﹤0.01%
300
TECX
4470
Tectonic Therapeutic
TECX
$529M
$21.9K ﹤0.01%
1,828
ARLP icon
4471
Alliance Resource Partners
ARLP
$3.34B
$21.9K ﹤0.01%
1,084
+1,022
+1,648% +$20.9K
CUE icon
4472
Cue Biopharma
CUE
$113M
$21.5K ﹤0.01%
201
NEUE
4473
DELISTED
NeueHealth
NEUE
$21.5K ﹤0.01%
1,220
+572
+88% +$29.5K
VHI icon
4474
Valhi
VHI
$380M
$21.3K ﹤0.01%
1,224
+576
+89% +$13K
TTM
4475
DELISTED
Tata Motors Limited
TTM
$21.1K ﹤0.01%
841
-105,989
-99% -$2.58M

Similar funds

Barclays's Q1 2023 Portfolio in Review

As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.

  • Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
  • Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
  • Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
  • Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
  • Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
  • Barclays opened 345 new positions and closed 541 in Q1 2023.
  • Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.